Cargando…

Immune cell phenotype and functional defects in Netherton syndrome

BACKGROUND: Netherton syndrome (NS) is a rare life-threatening syndrome caused by SPINK5 mutations leading to a skin barrier defect and a severe atopic diathesis. NS patients are prone to bacterial infections, but the understanding of the underlying immune deficiency is incomplete. RESULTS: We analy...

Descripción completa

Detalles Bibliográficos
Autores principales: Eränkö, Elina, Ilander, Mette, Tuomiranta, Mirja, Mäkitie, Antti, Lassila, Tea, Kreutzman, Anna, Klemetti, Paula, Mustjoki, Satu, Hannula-Jouppi, Katariina, Ranki, Annamari
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6258305/
https://www.ncbi.nlm.nih.gov/pubmed/30477583
http://dx.doi.org/10.1186/s13023-018-0956-6
_version_ 1783374470498484224
author Eränkö, Elina
Ilander, Mette
Tuomiranta, Mirja
Mäkitie, Antti
Lassila, Tea
Kreutzman, Anna
Klemetti, Paula
Mustjoki, Satu
Hannula-Jouppi, Katariina
Ranki, Annamari
author_facet Eränkö, Elina
Ilander, Mette
Tuomiranta, Mirja
Mäkitie, Antti
Lassila, Tea
Kreutzman, Anna
Klemetti, Paula
Mustjoki, Satu
Hannula-Jouppi, Katariina
Ranki, Annamari
author_sort Eränkö, Elina
collection PubMed
description BACKGROUND: Netherton syndrome (NS) is a rare life-threatening syndrome caused by SPINK5 mutations leading to a skin barrier defect and a severe atopic diathesis. NS patients are prone to bacterial infections, but the understanding of the underlying immune deficiency is incomplete. RESULTS: We analyzed blood lymphocyte phenotypes and function in relation to clinical infections in 11 Finnish NS patients, aged 3 to 17 years, and healthy age-matched controls. The proportion of B cells (CD19(+)) and naïve B cells (CD27(−), IgD(+)) were high while memory B cells (CD27(+)) and switched memory B cells (CD27(+)IgM(−)IgD(−)), crucial for the secondary response to pathogens, was below or in the lowest quartile of the reference values in 8/11 (73%) and 9/11 (82%) patients, respectively. The proportion of activated non-differentiated B cells (CD21(low), CD38l(ow)) was below or in the lowest quartile of the reference values in 10/11 (91%) patients. Despite normal T cell counts, the proportion of naïve CD4(+) T cells was reduced significantly and the proportion of CD8(+) T central memory significantly elevated. An increased proportion of CD57(+) CD8(+) T cells indicated increased differentiation potential of the T cells. The proportion of cytotoxic NK cells was elevated in NS patients in phenotypic analysis based on CD56DIM, CD16(+) and CD27(−) NK cells but in functional analysis, decreased expression of CD107a/b indicated impaired cytotoxicity. The T and NK cell phenotype seen in NS patients also significantly differed from that of age-matched atopic dermatitis (AD) patients, indicating a distinctive profile in NS. The frequency of skin infections correlated with the proportion of CD62L(+) T cells, naïve CD4(+) and CD27(+) CD8(+) T cells and with activated B cells. Clinically beneficial intravenous immunoglobulin therapy (IVIG) increased naïve T cells and terminal differentiated effector memory CD8(+) cells and decreased the proportion of activated B cells and plasmablasts in three patients studied. CONCLUSIONS: This study shows novel quantitative and functional aberrations in several lymphocyte subpopulations, which correlate with the frequency of infections in patients with Netherton syndrome. IVIG therapy normalized some dysbalancies and was clinically beneficial. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13023-018-0956-6) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6258305
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-62583052018-11-29 Immune cell phenotype and functional defects in Netherton syndrome Eränkö, Elina Ilander, Mette Tuomiranta, Mirja Mäkitie, Antti Lassila, Tea Kreutzman, Anna Klemetti, Paula Mustjoki, Satu Hannula-Jouppi, Katariina Ranki, Annamari Orphanet J Rare Dis Research BACKGROUND: Netherton syndrome (NS) is a rare life-threatening syndrome caused by SPINK5 mutations leading to a skin barrier defect and a severe atopic diathesis. NS patients are prone to bacterial infections, but the understanding of the underlying immune deficiency is incomplete. RESULTS: We analyzed blood lymphocyte phenotypes and function in relation to clinical infections in 11 Finnish NS patients, aged 3 to 17 years, and healthy age-matched controls. The proportion of B cells (CD19(+)) and naïve B cells (CD27(−), IgD(+)) were high while memory B cells (CD27(+)) and switched memory B cells (CD27(+)IgM(−)IgD(−)), crucial for the secondary response to pathogens, was below or in the lowest quartile of the reference values in 8/11 (73%) and 9/11 (82%) patients, respectively. The proportion of activated non-differentiated B cells (CD21(low), CD38l(ow)) was below or in the lowest quartile of the reference values in 10/11 (91%) patients. Despite normal T cell counts, the proportion of naïve CD4(+) T cells was reduced significantly and the proportion of CD8(+) T central memory significantly elevated. An increased proportion of CD57(+) CD8(+) T cells indicated increased differentiation potential of the T cells. The proportion of cytotoxic NK cells was elevated in NS patients in phenotypic analysis based on CD56DIM, CD16(+) and CD27(−) NK cells but in functional analysis, decreased expression of CD107a/b indicated impaired cytotoxicity. The T and NK cell phenotype seen in NS patients also significantly differed from that of age-matched atopic dermatitis (AD) patients, indicating a distinctive profile in NS. The frequency of skin infections correlated with the proportion of CD62L(+) T cells, naïve CD4(+) and CD27(+) CD8(+) T cells and with activated B cells. Clinically beneficial intravenous immunoglobulin therapy (IVIG) increased naïve T cells and terminal differentiated effector memory CD8(+) cells and decreased the proportion of activated B cells and plasmablasts in three patients studied. CONCLUSIONS: This study shows novel quantitative and functional aberrations in several lymphocyte subpopulations, which correlate with the frequency of infections in patients with Netherton syndrome. IVIG therapy normalized some dysbalancies and was clinically beneficial. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13023-018-0956-6) contains supplementary material, which is available to authorized users. BioMed Central 2018-11-26 /pmc/articles/PMC6258305/ /pubmed/30477583 http://dx.doi.org/10.1186/s13023-018-0956-6 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Eränkö, Elina
Ilander, Mette
Tuomiranta, Mirja
Mäkitie, Antti
Lassila, Tea
Kreutzman, Anna
Klemetti, Paula
Mustjoki, Satu
Hannula-Jouppi, Katariina
Ranki, Annamari
Immune cell phenotype and functional defects in Netherton syndrome
title Immune cell phenotype and functional defects in Netherton syndrome
title_full Immune cell phenotype and functional defects in Netherton syndrome
title_fullStr Immune cell phenotype and functional defects in Netherton syndrome
title_full_unstemmed Immune cell phenotype and functional defects in Netherton syndrome
title_short Immune cell phenotype and functional defects in Netherton syndrome
title_sort immune cell phenotype and functional defects in netherton syndrome
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6258305/
https://www.ncbi.nlm.nih.gov/pubmed/30477583
http://dx.doi.org/10.1186/s13023-018-0956-6
work_keys_str_mv AT erankoelina immunecellphenotypeandfunctionaldefectsinnethertonsyndrome
AT ilandermette immunecellphenotypeandfunctionaldefectsinnethertonsyndrome
AT tuomirantamirja immunecellphenotypeandfunctionaldefectsinnethertonsyndrome
AT makitieantti immunecellphenotypeandfunctionaldefectsinnethertonsyndrome
AT lassilatea immunecellphenotypeandfunctionaldefectsinnethertonsyndrome
AT kreutzmananna immunecellphenotypeandfunctionaldefectsinnethertonsyndrome
AT klemettipaula immunecellphenotypeandfunctionaldefectsinnethertonsyndrome
AT mustjokisatu immunecellphenotypeandfunctionaldefectsinnethertonsyndrome
AT hannulajouppikatariina immunecellphenotypeandfunctionaldefectsinnethertonsyndrome
AT rankiannamari immunecellphenotypeandfunctionaldefectsinnethertonsyndrome